Bioscience & Health Care

The University advances innovation in bioscience and health care delivery by supporting research and sustained growth for startups and bioscience initiatives. Partnerships with powerful industry leaders like INOVA create impact throughout the state and beyond.

Filter by Region, Sector, or Focus
Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.
One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.
The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.
CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.
Starting from the campus of the University of Virginia, AgroSpheres has created a comprehensive biomodality platform, injecting strong momentum into the sustainable development of global agriculture.
A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.
Afton Scientific will deepen its roots in Central Virginia with the assistance of a Youngkin-approved grant from the Commonwealth's Development Opportunity Fund.
AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.
The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.
Much of the industry's success wouldn't be possible without the talent that comes out of UVA, which has developed various ways to support researchers.
The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.
Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).